Table 1 Clinical characteristics of analyzed EOC patients
Criteria | Sporadic EOC | Mutated EOC | ||
|---|---|---|---|---|
n | % | n | % | |
FIGO | Â | Â | Â | Â |
I | 13 | 6.9 | 3 | 20.0 |
II | 6 | 3.2 | 0 | 0.0 |
III/IV | 165 | 87.8 | 12 | 80.0 |
Missing | 4 | 2.1 | 0 | 0.0 |
Grading | Â | Â | Â | Â |
G1 | 6 | 3.2 | 3 | 20.0 |
G2 | 29 | 15.4 | 2 | 13.3 |
G3 | 147 | 78.2 | 10 | 66.7 |
Missing | 6 | 3.2 | 0 | 0.0 |
pT | Â | Â | Â | Â |
T1a | 6 | 3.2 | 1 | 6.7 |
T1b | 1 | 0.5 | 0 | 0.0 |
T1c | 7 | 3.7 | 2 | 13.3 |
T2a | 8 | 4.3 | 0 | 0.0 |
T2c | 7 | 3.7 | 0 | 0.0 |
T3a | 8 | 4.3 | 0 | 0.0 |
T3b | 20 | 10.6 | 2 | 13.3 |
T3c | 129 | 68.6 | 10 | 66.7 |
Missing | 2 | 1.1 | 0 | 0.0 |
pN | Â | Â | Â | Â |
N0 | 60 | 31.9 | 5 | 33.3 |
N1 | 114 | 60.6 | 7 | 46.7 |
Nx | 14 | 7.4 | 3 | 20.0 |
pM | Â | Â | Â | Â |
M0 | 137 | 72.9 | 12 | 80.0 |
M1 | 35 | 18.6 | 3 | 20.0 |
Mx | 16 | 8.5 | 0 | 0.0 |
Histology | Â | Â | Â | Â |
Serous | 156 | 83.0 | 13 | 86.7 |
Endometrioid | 15 | 8.0 | 0 | 0.0 |
Mucinous | 3 | 1.6 | 2 | 13.3 |
Other | 14 | 7.4 | 0 | 0.0 |
Resection | Â | Â | Â | Â |
R0 | 141 | 75.0 | 12 | 80.0 |
R1/R2 | 42 | 22.3 | 3 | 20.0 |
Missing | 5 | 2.7 | 0 | 0.0 |
Chemotherapy | Â | Â | Â | |
Carbo/Pac | 150 | 79.8 | 13 | 86.7 |
Carbo | 8 | 4.3 | 0 | 0.0 |
Carbo/Pac + x | 11 | 5.9 | 0 | 0.0 |
Carbo + x | 8 | 4.3 | 1 | 6.7 |
Other | 3 | 1.6 | 0 | 0.0 |
None | 7 | 3.7 | 1 | 6.7 |
Missing | 1 | 0.5 | 0 | 0.0 |
Bevacizumab | Â | Â | Â | |
Yes | 29 | 15.4 | 5 | 33.3 |
No | 157 | 83.5 | 10 | 66.7 |
Missing | 2 | 1.1 | 0 | 0.0 |
Complete | 188 | 100.0 | 15 | 100.0 |